Hepatitis C Virus 4th Generation 65 Kda (HCV) Recombinant Protein

Description: The E Coli derived recombinant protein contains a HCV fourth generation antigen, containing medium size core NS3, 3 & 2 epitopes from NS4 and NS5, respectively. The genotype of all sequences is 1b. The recombinant protein migrates at 65kDa. This fourth generation HCV antigen is suitable to produce HCV lateral flow immunoassay product. The test steps include 5ul serum or plasma, then add 60-70ul assay buffer. The HCV rapid test prepared by this antigen generates high sensitivity required by CE mark or FDA 510K.

Introduction: HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6).

Small volumes of HCV recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS146621 is a recombinant protein targeting HCV. Also known as Recombinant Hepatitis C Virus 4th Generation 65 kDa. Host: E Coli.